🇺🇸 FDA
Patent

US 7288254

Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation

granted A61KA61K38/00A61K47/6817

Quick answer

US patent 7288254 (Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation) held by The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary Department of Health and Human Services (NIH)
Grant date
Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K47/6817, A61K47/6849